eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
 
1/2013
vol. 51
 
Share:
Share:
more
 
 
abstract:
Review paper

Hematologic features of systemic lupus erythematosus

Paweł Hrycaj
,
Dorota Cieślak

Reumatologia 2013; 51, 1: 31-35
Online publish date: 2013/03/05
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Changes in the hematopoietic system are characteristic features of systemic lupus erythematosus (SLE). Anemia of chronic disease is the most common, whereas autoimmune hemolytic anemia, anemia associated with iron deficiency or renal failure, and iatrogenic anemia (associated with the use of cytotoxic drugs) occur less frequently. Leucopenia, lymphopenia and thrombocytopenia are the other common symptoms of SLE. Causes of hematological disorders in SLE are complex and include autoimmune damage to the bone marrow and peripheral blood cells, erythropoietin deficiency, infections, drug-induced disorders, bone marrow fibrosis and hypersplenism. In the treatment of SLE-related cytopenias glucocorticoids and cytotoxic drugs (azathioprine, cyclosporine A, and mycophenolatemofetil) are used. High doses of intravenous immunoglobulins and danazol are effective in the treatment of thrombocytopenia. Cyclophosphamide is beneficial in severe and refractory thrombocytopenia. Splenectomy and bone marrow transplant may also be considered.
keywords:

anemia, leucopenia, thrombocytopenia, systemic lupus erythematosus






Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe